2.01

9.24% 0.17

Black Diamond Therapeutics Inc (BDTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$1.84

Offen:

$1.83

24-Stunden-Volumen:

1.57M

Relative Volume:

0.98

Marktkapitalisierung:

$115.18M

Einnahmen:

$70.00M

Nettoeinkommen (Verlust:

$-43.21M

KGV:

-2.6521

EPS:

-0.7579

Netto-Cashflow:

$-34.03M

1W Leistung:

+18.24%

1M Leistung:

-7.80%

6M Leistung:

-19.28%

1J Leistung:

-22.69%

1-Tages-Spanne:

$1.83

$2.035

1-Wochen-Bereich:

$1.68

$2.035

52-Wochen-Spanne:

$1.60

$4.94

Black Diamond Therapeutics Inc Stock (BDTX) Company Profile

Firmenname

Black Diamond Therapeutics Inc

Sektor

Healthcare (1098)

Branche

Biotechnology (615)

Telefon

617-417-5868

Adresse

245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-06

Neueste SEC-Einreichungen

BDTX's Discussions on Twitter

Compare BDTX vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BDTX Black Diamond Therapeutics Inc	2.01	106.01M	70.00M	-43.21M	-34.03M	-0.7579
VRTX Vertex Pharmaceuticals Inc	528.04	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	654.27	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	939.68	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	312.78	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.24	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-03	Herabstufung	Guggenheim	Buy → Neutral
2025-11-18	Fortgesetzt	Piper Sandler	Overweight
2025-10-16	Fortgesetzt	Stifel	Buy
2025-09-04	Eingeleitet	Guggenheim	Buy
2025-07-01	Fortgesetzt	Raymond James	Outperform
2024-07-31	Eingeleitet	Raymond James	Outperform
2023-07-14	Eingeleitet	Piper Sandler	Overweight
2023-06-30	Hochstufung	Stifel	Hold → Buy
2023-06-28	Hochstufung	H.C. Wainwright	Neutral → Buy
2023-06-27	Hochstufung	Wedbush	Neutral → Outperform
2022-03-29	Herabstufung	Wedbush	Outperform → Neutral
2022-03-22	Herabstufung	H.C. Wainwright	Buy → Neutral
2021-09-30	Eingeleitet	Stifel	Hold
2021-01-07	Eingeleitet	Wedbush	Outperform
2020-11-24	Eingeleitet	Berenberg	Buy
2020-05-04	Eingeleitet	H.C. Wainwright	Buy
2020-02-24	Eingeleitet	Canaccord Genuity	Buy
2020-02-24	Eingeleitet	Cowen	Outperform
2020-02-24	Eingeleitet	JP Morgan	Overweight
2020-02-24	Eingeleitet	Jefferies	Buy

Alle ansehen

Black Diamond Therapeutics Inc Aktie (BDTX) Neueste Nachrichten

Jun 30, 2026

Black Diamond Therapeutics touts Silevertinib lung cancer data, eyes FDA path - MSN

Jun 30, 2026

Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Raman Prakash - Moomoo

Jun 30, 2026

Jun 29, 2026

Black Diamond Therapeutics 2026 Annual Stockholder Meeting Results and Voting Outcomes - Minichart

Jun 29, 2026

Form 4 Black Diamond Therapeutics Inc For: 29 June By Investing.com - Investing.com Nigeria

Jun 29, 2026

[Form 4] Black Diamond Therapeutics, Inc. Insider Trading Activity - Stock Titan

Jun 29, 2026

Black Diamond (BDTX) director awarded 40,000 stock options at $1.71 - Stock Titan

Jun 29, 2026

Black Diamond Therapeutics (BDTX) director awarded 40,000 stock options at $1.71 - Stock Titan

Jun 29, 2026

Director Garry Menzel granted 40,000 BDTX stock options at $1.71 strike - Stock Titan

Jun 29, 2026

Black Diamond (NASDAQ: BDTX) director receives 40,000 stock options at $1.71 - Stock Titan

Jun 29, 2026

Black Diamond Therapeutics (BDTX) awards 40,000-share option grant - Stock Titan

Jun 29, 2026

Black Diamond Therapeutics (BDTX) 2026 meeting backs directors, auditor and annual say-on-pay - Stock Titan

Jun 29, 2026

Black Diamond Therapeutics, Inc.(NasdaqGS: BDTX) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026

Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Black Diamond Therapeutics, Inc.(NasdaqGS: BDTX) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026

Enterprise value to EBITDA forward of Black Diamond Therapeutics, Inc. – NASDAQ:BDTX - TradingView

Jun 29, 2026

Jun 28, 2026

Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 3000 Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Black Diamond Therapeutics (BDTX) AGM 2026 Summary - Quartr

Jun 26, 2026

Price to sales forward of Black Diamond Therapeutics, Inc. – NASDAQ:BDTX - TradingView

Jun 26, 2026

Price to book forward of Black Diamond Therapeutics, Inc. – BOATS:BDTX - TradingView

Jun 26, 2026

Black Diamond Therapeutics, Inc. Actuals & Estimates (NASDAQ:BDTX) - TradingView

Jun 26, 2026

Jun 25, 2026

Enterprise value to EBIT forward of Black Diamond Therapeutics, Inc. – NASDAQ:BDTX - TradingView

Jun 25, 2026

Price to earnings forward of Black Diamond Therapeutics, Inc. – BOATS:BDTX - TradingView

Jun 25, 2026

Price to sales forward of Black Diamond Therapeutics, Inc. – BOATS:BDTX - TradingView

Jun 25, 2026

Enterprise value to revenue forward of Black Diamond Therapeutics, Inc. – BOATS:BDTX - TradingView

Jun 25, 2026

BDTX shares gain 11% in a week: Here's what you should know - MSN

Jun 25, 2026

BDTX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 23, 2026